BC Innovations | Apr 5, 2017
Distillery Therapeutics


INDICATION: Colorectal cancer; ovarian cancer Mouse studies suggest a CXCL11 -overexpressing oncolytic vaccinia virus that up-regulates PD-L1 could help treat colorectal and ovarian cancers. An oncolytic vaccinia virus that naturally up-regulates PD-L1 in infected cells...
BC Innovations | May 8, 2014
Distillery Therapeutics

Indication: Autoimmune disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Autoimmune disease Autoimmune disease; multiple sclerosis (MS) Chemokine CXC motif ligand 11 (CXCL11) Mouse studies suggest low doses of CXCL11 could be useful for treating autoimmune...
Items per page:
1 - 2 of 2